Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
89%
Ph early_phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
Not yet recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

active_not_recruiting111%
recruiting222%
not_yet_recruiting222%
unknown111%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9